The most common bacteria isolated from Neonatal Intensive Care Unit at Baghdad Teaching Hospital/ Medical City
DOI:
https://doi.org/10.61841/scftck77Keywords:
Neonatal Intensive Care Unit, Baghdad Teaching Hospital, Pathogenic bacteria, Pseudomonas aerugenosa, Klebsiella pneumoniae, E. coli, Enterobacter sakazaki, Acinetobacter baumanii, Bacillus spp., Staphylococcus epidermidisAbstract
The present study is interested in the detection of the most common bacteria that contaminate the Neonatal Intensive Care Unit at Baghdad Teaching Hospital/Medical City; therefore, a total of 150 swab samples were collected from many inanimate objects (equipment and surfaces) at the Neonatal Intensive Care Unit (NICU) during the period from Aug. to Oct. 2019. All swab samples were cultured on routine culture media and incubated at 37 ºC for 24 hrs. 53 (35.33%) out of 150 (100%) swab samples gave positive culture, and the isolates were identified by traditional microbiological methods including morphological and microscopical characteristics and biochemical tests of the API system. The study provides evidence that the most common bacterial species that contaminate the inanimate objects (equipment and surfaces) at NICU/Baghdad Teaching Hospital were Pseudomonas aeruginosa and Klebsiella pneumoniae. E. coli, Enterobacter sakazaki, Acinetobacter baumannii, Bacillus spp., and Staphylococcus epidermidis.
Downloads
References
Okomo, UA; (2018) Neonatal Infections; a hospital-based study in The Gambia examining aetiology and associated
maternal colonization. PhD thesis, London School of Hygiene & Tropical Medicine.
Bokulich, N. A.; Mills, D.A.; and Underwood, M.A. (2013). Surface Microbes in the Neonatal Intensive Care Unit: Changes
with routine cleaning and over time. J Clin Microbiol. 51(8): 2617–2624.
Hewitt, K.M.; Mannino, F.L.; Gonzalez, A.; Chase, J.H.; Caporaso, J.G.; Knight, R.; and Kelley, S.T. (2013). Bacterial
Diversity in Two Neonatal Intensive Care Units (NICUs). Am J Infect Control 8(1).
Hota B (2004) Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial
infection? Clin Infect Dis 39: 1182–1189.
Abdullah Hasan et al., 2018, Chemical synthesis and characterization of silver nanoparticles induced biocompatibility for
anticancer activity,'' Indian Journal of Public Health Research & Development, 9 (11), 352-357
Fatima Amer Abd Algabar, Sawsan Hassan Authman & KJK, ''Cytotoxicity anticancer activities of staphyloxanthin
against breast, liver hepatocellular and lung cancer cell,'' Biochem Cell Arch, 2018, 18 (1), 25-30
Kramer, A., Schwebke, I., & Kampf, G. (2006). How long do nosocomial pathogens persist on inanimate surfaces? A systematic
review. BMC Infect Dis 6: 130.
Huang SS, Datta R, Platt R (2006) Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern
Med 166: 1945–1951.
Hota B, Blom DW, Lyle EA, Weinstein RA, Hayden MK (2009) Interventional evaluation of environmental
Contamination by vancomycin-resistant enterococci: failure of personnel, product, or procedure? J Hosp Infect 71: 123–131.
Tringe SG, Hugenholtz P (2008) A renaissance for the pioneering 16S rRNA gene. Curr Opin Microbiol 11: 442–446.
MacFaddin, J.F. (2000). Biochemical tests for the identification of medical bacteria, 3PrdP ed., The Williams and Wilkins, Baltimore, USA
Orji, M.; Mbata, T.; and Kalu, O. (2005). Isolation of pathogenic bacteria from hospital staff apparel in Nigeria. Malawi
Med J. ; 17(4): 128–130.
Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL (2001) Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 29: 152–157.
Urrea M, Iriondo M, Thio M, Krauel X, Serra M, et al. (2003) A prospective incidence study of nosocomial infections in a neonatal care unit. Am J Infect Control 31: 505–507.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
